{"id":917033,"date":"2021-04-06T14:14:30","date_gmt":"2021-04-06T18:14:30","guid":{"rendered":"https:\/\/www.finder.com\/ca\/?p=917033"},"modified":"2026-06-17T20:33:40","modified_gmt":"2026-06-18T00:33:40","slug":"psychedelic-stocks","status":"publish","type":"post","link":"https:\/\/www.finder.com\/ca\/stock-trading\/psychedelic-stocks","title":{"rendered":"6 psychedelic stocks to watch"},"content":{"rendered":"

For many investors, the experimental psychedelics industry may be too risky to invest in. Most companies in this sector are privately held, and psychedelic stocks are often volatile penny or OTC stocks.<\/p>

Aside from being risky, these stocks can also be difficult to purchase. Most stocks will require you to have a brokerage account that offers access to OTC and international stocks, like Interactive Brokers.<\/p>

For investors willing to take the risk, the best psychedelic stocks depend on your portfolio and investment goals\u2014while volatility can be ideal for day traders, long-term investors will want to look to stocks with steadier gains over time.<\/p>\n\n\n \n \n \n \n \n\n \n\n

6 popular psychedelic stocks to watch<\/h3>\n\n

We round up a selection of stocks in or related to the experimental drug industry, weighting the list more heavily towards popular mid- and large-cap stocks.<\/p>\n\n\n\n\n \n\n \n \n \n \n \n \n \n \n
Best stock<\/th>\n 1-year return<\/strong><\/th>\n Market cap<\/strong><\/th>\n Exchange<\/strong><\/th>\n Volume<\/strong><\/th>\n Buy on Questrade<\/th>\n<\/tr>\n<\/thead>\n
Compass Pathways\u00a0Plc (CMPS.US)<\/strong><\/td>\n \n \n \n <\/use><\/svg>433.19%Compass Pathways Plc's 1-year return based on the closing price as of June 23, 2025.<\/span>\n<\/button>\n<\/td>\n \n \n\n\n \n \n $1.6 billion (USD)\n \n<\/td>\n NASDAQ<\/td>\n 3,625,329<\/td>\n Buy now<\/a><\/td>\n <\/tr>\n \n \n
Definium Therapeutics (DFTX.US)<\/strong><\/td>\n \n \n \n <\/use><\/svg>247.23%Definium Therapeutics's 1-year return based on the closing price as of June 20, 2025.<\/span>\n<\/button>\n<\/td>\n \n \n\n\n \n \n $2.7 billion (USD)\n \n<\/td>\n NASDAQ<\/td>\n 2,629,900<\/td>\n Buy now<\/a><\/td>\n <\/tr>\n \n \n
Cybin IncCommon Stock (HELP.US)<\/strong><\/td>\n \n \n \n <\/use><\/svg>-37.66%Cybin IncCommon Stock's 1-year return based on the closing price as of June 20, 2025.<\/span>\n<\/button>\n<\/td>\n \n \n\n\n \n \n $214.5 million (USD)\n \n<\/td>\n NASDAQ<\/td>\n 729,967<\/td>\n Buy now<\/a><\/td>\n <\/tr>\n \n \n
ATAI Life Sciences BV (ATAI.US)<\/strong><\/td>\n \n \n \n <\/use><\/svg>100.99%ATAI Life Sciences BV's 1-year return based on the closing price as of June 23, 2025.<\/span>\n<\/button>\n<\/td>\n \n \n\n\n \n \n $1.5 billion (USD)\n \n<\/td>\n NASDAQ<\/td>\n 6,625,000<\/td>\n Buy now<\/a><\/td>\n <\/tr>\n \n \n
Psyched Wellness (PSYC.CN)<\/strong><\/td>\n \n \n \n <\/use><\/svg>-66.67%Psyched Wellness's 1-year return based on the closing price as of June 20, 2025.<\/span>\n<\/button>\n<\/td>\n \n \n\n\n \n \n $4.1 million (CAD)\n \n<\/td>\n Canadian Securities Exchange<\/td>\n 11,040<\/td>\n Buy now<\/a><\/td>\n <\/tr>\n \n \n
Field Trip Health (FTRP.CN)<\/strong><\/td>\n \n \n \n (data unavailable)\n<\/td>\n \n \n\n\n \n \n $210.8 million (CAD)\n \n<\/td>\n Canadian Securities Exchange<\/td>\n (data unavailable)<\/td>\n Buy now<\/a><\/td>\n <\/tr>\n\n<\/tbody>\n<\/table>\nThe values in this table are accurate as of the market close on June 17, 2026, or the most recent data available. Volume refers to the number of shares traded during the day.<\/small>\n\n \n \n \n \n\n

What to look for when investing in psychedelic stock<\/h3>\n\n

The experimental drug industry is affected by a range of complex factors such as trade policies, regulations, and fluctuating supply and demand. So when considering psychedelic stocks to buy, it's important that you have access to vital information about a company's financial health, leadership team, and market positioning.<\/p>\n\n

Also keep in mind that, while volatility can be ideal for day traders, long-term investors will want to look for stocks to offer steadier gains over time.<\/p>\n\n\n \n \n \n \n\n\n\n

How to invest in psychedelic stock<\/h3>\n
    \n
  1. Research the experimental drug industry.<\/strong> Before investing, learn about the psychedelic stock sector, its trends and the companies within it. Look at each company's financial health, potential for growth and past performance to identify stocks that fit your investment goals.<\/li>\n
  2. Choose a stock trading platform.<\/strong> Compare trading fees, access to trading tools and user interface options. We've identified reliable trading platforms to help narrow down your options below or check out the best stock trading apps in Canada<\/a> to find one that suits your needs.<\/li>\n
  3. Open and fund your account.<\/strong> Sign up with your personal details and link a bank account or funding method to deposit money before you start trading.<\/li>\n
  4. Select the psychedelic stock(s) to buy.<\/strong> Search by company name or ticker symbol, like CMPS or DFTX. Compare key metrics such as market cap, price history and earnings per share to pick the best stock for your strategy.<\/li>\n
  5. Buy the stock and monitor performance.<\/strong> Place your order to buy the stock and track its performance over time. Consider setting alerts, signing up for industry newsletters or using platform research tools to stay up to date on market changes.<\/li>\n<\/ol>\n\n

    Our top picks for where to buy psychedelic stocks<\/h3>\n <\/a>\n \n\n